Literature DB >> 21537065

Comparison of virulence markers and antibiotic resistance in enterotoxigenic Escherichia coli isolated ten years apart in Tehran.

Nader Shahrokhi1, Saeid Bouzari, Anis Jafari.   

Abstract

INTRODUCTION: Enterotoxigenic Escherichia coli (ETEC) causes diarrhoea by producing heat-labile (LT) or heat-stable (ST) enterotoxins after colonizing the small intestine by means of colonization factors (CFs). Although detection of the toxins is sufficient for verification of ETEC isolates, toxin-positive strains may be further analyzed for the presence of CFs. Antibiotics may shorten the duration of diarrhoea caused by ETEC, but the rapid emergence of resistant strains limits their usefulness.
METHODOLOGY: ETEC isolates collected 10 years apart were compared for the prevalence of toxin types, CFs and antibiotic resistance. DNA/DNA hybridization with digoxigenin (DIG)-labeled probes was used for the detection of toxin types, and CF-typing was performed by DNA hybridization using DIG-labeled probes for cfaD and CS6 with slide agglutination. Disk diffusion was used to determine antibiotic resistance. The presence of class 1 integrons was detected by PCR.
RESULTS: ST-positive isolates were the most prevalent among the isolates from 1988, but a significant shift towards LT-gene carriage was observed in the 1998 group. CFA/I and CFA/IV were the most common CF types within both groups. The most prevalent resistance patterns among these isolates were ACSTSXT followed by ASTSXT and ASSXT.
CONCLUSION: Our study of the two groups of isolates showed that the rate of LT and ST gene carriage, as well as antibiotic resistance markers, has changed in the ten years separating the two bacterial populations. These variations show the importance of monitoring pathogenic bacteria to obtain a near realistic picture of the circulating bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537065     DOI: 10.3855/jidc.1206

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  7 in total

1.  Profiling Virulence and Antimicrobial Resistance Markers of Enterovirulent Escherichia Coli from Fecal Isolates of Adult Patients with Enteric Infections in West Cameroon.

Authors:  Wiliane J T Marbou; Priyanka Jain; Sriparna Samajpati; Gourab Halder; Asish K Mukhopadhyay; Shanta Dutta; Victor Kuete
Journal:  Osong Public Health Res Perspect       Date:  2020-08

2.  Pathogenicity and phenotypic characterization of enterotoxigenic Escherichia coli isolates from a birth cohort of children in rural Egypt.

Authors:  Adel Mansour; Hind I Shaheen; Mohamed Amine; Khaled Hassan; John W Sanders; Mark S Riddle; Adam W Armstrong; Ann-Mari Svennerholm; Peter J Sebeny; John D Klena; Sylvia Y N Young; Robert W Frenck
Journal:  J Clin Microbiol       Date:  2013-12-11       Impact factor: 5.948

3.  Molecular Characterization of Enterotoxin-Producing Escherichia coli Collected in 2011-2012, Russia.

Authors:  Nikolay N Kartsev; Nadezhda K Fursova; Dmitry M Pachkunov; Vasiliy A Bannov; Boris V Eruslanov; Edward A Svetoch; Ivan A Dyatlov
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

4.  Phylogenetic background of enterotoxigenic and enteroinvasive Escherichia coli from patients with diarrhea in Sirjan, Iran.

Authors:  Taifeh Hoseinzadeh; Reza Ghanbarpour; Farokh Rokhbakhsh-Zamin
Journal:  Iran J Microbiol       Date:  2016-06

5.  Diarrheagenic Escherichia coli pathotypes frequency in Khuzestan province of Iran.

Authors:  Atieh Darbandi; Parviz Owlia; Saeid Bouzari; Horieh Saderi
Journal:  Iran J Microbiol       Date:  2016-12

6.  Escherichia coli: a brief review of diarrheagenic pathotypes and their role in diarrheal diseases in Iran.

Authors:  A Jafari; M M Aslani; S Bouzari
Journal:  Iran J Microbiol       Date:  2012-09

7.  Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities.

Authors:  Mahdi Rohani; Nasrin Noohi; Malihe Talebi; Mohammad Katouli; Mohammad R Pourshafie
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.